IMTP.PA
Latest Trade
35.80EURChange
-0.20(-0.56%)Volume
193,240Today's Range
-
36.5052 Week Range
-
58.05As of on the Euronext Paris ∙ Minimum 15 minute delay
Previous Close | 36.00 |
|---|---|
Open | 35.96 |
Volume | 193,240 |
3M AVG Volume | 3.60 |
Today's High | 36.50 |
Today's Low | 35.60 |
52 Week High | 58.05 |
52 Week Low | 32.84 |
Shares Out (MIL) | 79.25 |
Market Cap (MIL) | 2,861.49 |
Forward P/E | 9.22 |
Dividend (Yield %) | 5.76 |
Imerys Appoints Patrick Kron As Chairman Of Board Of Directors
Imerys Expects EUR 100 Million Cost Savings In Full In 2022
Imerys Q1 Net Income Group Share Down At EUR 67.2 Million
Imerys SA is a France-based company that is principally engaged in the extraction and processing of minerals. The Company is organized into four Business Groups: Minerals for Ceramics, Refractories, Abrasives and Foundry, which provides a range of products, such as ceramic bodies for porcelain, raw materials for floor tiles and graphite powders; Materials & Monolithics, producing and distributing roofing and structural products, such as roof tiles, bricks and chimney blocks, as well as monolithic refractories; Pigments for Paper and Packaging, which consists of the Company's activities in kaolin and calcium carbonate for the paper industry and Performance & Filtration Minerals, which deals with the processing of kaolin, carbonates, feldspar, vermiculite and diatomite, among others. It operates through Damolin and PyraMax Ceramics LLC, Kerneos SA and Micron-Ita, among others.
Industry
Construction - Raw Materials
Contact Info
43 quai de Grenelle
+33.1.49556300
http://www.imerys.com/scopi/group/imeryscom/imeryscom.nsf/pagesref/SLMM-8RGJYT?opendocument&lang=enExecutive Leadership
Patrick Kron
Independent Chairman of the Board
Conrad Keijzer
Chief Executive Officer, Member of the Executive Committee, Director
Paul Desmarais
Vice Chairman of the Board
Olivier Pirotte
Chief Financial Officer, Member of the Executive Committee
Vincent Lecerf
Chief Human Resources Officer, Member of the Executive Committee
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 0.63 |
Price To Book (MRQ) | 0.92 |
Price To Cash Flow (TTM) | 189.50 |
Total Debt To Equity (MRQ) | 77.91 |
LT Debt To Equity (MRQ) | 67.77 |
Return on Investment (TTM) | -5.03 |
Return on Equity (TTM) | -3.94 |
The Missouri Supreme Court on Thursday halted an upcoming trial in a case brought by women who claim talc supplied by Imerys Talc America for use in Johnson & Johnson products gave them cancer, saying it wanted to consider a jurisdictional challenge by Imerys.
Women alleging in a multidistrict litigation that Johnson & Johnson and Imerys Talc America's talc-based products cause ovarian cancer have said Imerys should not be allowed to retrieve certain emails it turned over in discovery and that those emails should be made public.
Plaintiffs alleging that Johnson & Johnson and Imerys Talc America's baby powder contains cancer-causing asbestos accused the companies on Wednesday of engaging in "significant" discovery violations by withholding documents and talc samples until the "eleventh hour."
The following are mergers under review by the European Commission and a brief guide to the EU merger process:
The following are mergers under review by the European Commission and a brief guide to the EU merger process:
French roofing business Imerys has set final terms on a €580m leveraged loan with a heavy discount on a newly introduced €100m second-lien loan.
A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least $5 million, Bloomberg reported on Friday, citing people familiar with the matter.
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:
France's Imerys <IMTP.PA> is selling its roof tiles business as it streamlines its portfolio, people close to the matter said, expecting the asset to be valued at around 1 billion euros ($1.2 billion), with private equity most likely to clinch the deal.
Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.
Johnson & Johnson and an Imerys SA unit must pay an additional $80 million in punitive damages in a lawsuit claiming a man developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.
AURELIUS EQUITY OPPORTUNITIES SE & CO KGAA:
The European Commission said on Friday it had approved French minerals company Imerys's <IMTP.PA> acquisition of alumina producer Alteo ARC and Alufin GmbH Tabularoxid, subject to conditions.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.